Halozyme Therapeutics
HALO
#2125
Rank
C$13.20 B
Marketcap
C$111.33
Share price
0.56%
Change (1 day)
46.35%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): C$0.69 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.50 Billion. In 2025 the company made an earning of C$0.65 Billion a decrease over its 2024 earnings that were of C$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.69 B5.88%
2025 C$0.65 B-16.2%
2024 C$0.78 B59.94%
2023 C$0.49 B39.94%
2022 C$0.35 B0.16%
2021 C$0.35 B92.2%
2020 C$0.18 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$86.78 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$45.4 Million-52.86%
2014 -C$96.32 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$75.44 Million169.94%
2011 -C$27.95 Million-63.44%
2010 -C$76.43 Million-7.19%
2009 -C$82.35 Million15.91%
2008 -C$71.05 Million83.89%
2007 -C$38.64 Million78.1%
2006 -C$21.7 Million16%
2005 -C$18.7 Million45.24%
2004 -C$12.88 Million682.42%
2003 -C$1.65 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.59 B 5,060.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.91 B 2,004.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.84 B 6,083.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.78 B 1,421.43%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.72 Billion-200.92%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$40.26 Million-105.68%๐Ÿ‡บ๐Ÿ‡ธ USA